Myeloschisis is a rare birth condition in which the spinal cord does not close and remains open at the back. In plain terms, myeloschisis is a severe form of spinal dysraphism that is usually recognized before birth or at delivery. Early signs of myeloschisis can include exposed spinal tissue, weakness or paralysis in the legs, and problems with bladder or bowel control. Myeloschisis is lifelong, and the outlook depends on how much of the spinal cord is affected and whether there are related complications such as infection. Treatment does not reverse myeloschisis, but surgery, skin protection, rehabilitation, and ongoing bladder, bowel, and mobility care can improve comfort and daily function.
How many people live with Myeloschisis?
Myeloschisis, a very rare severe birth condition that affects the spine and spinal cord, does not have a widely accepted worldwide or U.S. count reported on its own. Large health sources usually group it together with other forms of open spina bifida or neural tube defects, so a separate estimate for how many people are living with myeloschisis worldwide or in the United States is not reliably available.
Overview
MyeloschisisSymptoms
Myeloschisis is a severe open spinal cord defect present at birth. Features often include exposed nerve tissue on the back, leg weakness or paralysis, loss of bladder and bowel control, and sometimes other brain and spine problems.
Outlook and prognosis
Myeloschisis is a severe open spinal cord condition, so outlook is often serious from birth. Many living with myeloschisis need urgent surgery and long-term care, and can have lasting weakness or paralysis, bladder and bowel problems, and a higher risk of brain fluid buildup.
Causes and risk factors
Myeloschisis usually develops very early in pregnancy from a severe neural tube defect. Risk is higher with low folate, certain anti-seizure medicines, poorly controlled diabetes, obesity, high body temperature early in pregnancy, and sometimes genetic susceptibility.
Genetic influences
Genetics can raise the risk of myeloschisis, but it is usually not caused by a single inherited gene change. Many living with myeloschisis are affected by a mix of genetic susceptibility and environmental factors, especially low folate early in pregnancy.
Diagnosis
Myeloschisis is usually diagnosed by clinical features and imaging findings. The diagnosis of Myeloschisis often starts during pregnancy with ultrasound, sometimes supported by blood tests. After birth, the open spinal defect is usually obvious on exam.
Treatment and drugs
Myeloschisis needs urgent care at birth to protect the exposed spinal cord and lower infection risk. Surgery usually closes the opening soon after delivery. Ongoing treatment may include physical therapy, mobility support, and bladder, bowel, or hydrocephalus care.
Symptoms
Myeloschisis is a severe birth difference in which part of the spinal cord is open on the back instead of being covered by skin. The effects depend a lot on where along the spine it occurs, but movement, feeling, and bladder or bowel control below that area are often affected. In daily routines, this might show up as small but noticeable changes, from needing help with mobility to needing ongoing skin and bladder care. The early features of Myeloschisis are usually obvious at birth.
At birth, there is usually a flat, open area on the back where delicate nerve tissue is exposed. This needs urgent specialist care because the tissue can dry out, be injured, or become infected.
Many people with Myeloschisis have weakness or paralysis in the legs below the spinal opening. For many, this can mean delayed motor milestones, a need for braces, or wheelchair use, depending on the level affected.
Sensation below the affected level may be lower than usual or absent. This can make it easier to miss cuts, burns, or pressure sores during everyday activities.
Nerve signals to the bladder often do not work well, leading to leakage, trouble emptying, or repeated urinary infections. Many living with Myeloschisis need a regular bladder care plan to help protect kidney health.
How people usually first notice Myeloschisis?
Myeloschisis is usually first noticed before birth on a prenatal ultrasound or through blood tests in pregnancy that suggest an open neural tube defect, meaning the spinal cord did not close and is exposed. When it is seen at birth, doctors and families usually notice a visible opening along the baby’s back, often with exposed nerve tissue, and many infants also have weakness or little movement in the legs. Because the first signs of myeloschisis are typically obvious very early, babies need urgent specialist care right away.
Types of Myeloschisis
No distinct types of Myeloschisis are widely recognized.
Can I slow down the onset of symptoms?
No. Myeloschisis happens when the spinal cord does not close normally very early in pregnancy, so there is no proven way to slow or delay symptoms once it has started, but the chance of this kind of birth difference can be lowered before and in very early pregnancy by getting enough folic acid, managing diabetes well, avoiding very high body heat such as hot tubs or saunas, and reviewing seizure medicines with a doctor if needed. Early prenatal care and pregnancy screening can help find it sooner, and while these steps cannot prevent every case, they are still the most helpful proven ways to lower risk.
What genetics can tell you about symptoms
For people living with myeloschisis, genetics can help explain part of the risk of developing this severe spinal cord birth difference, but it usually cannot predict exactly which symptoms will happen in an individual baby. Changes in several genes involved in early spinal development and folate use may influence susceptibility, while symptoms such as weakness or paralysis, loss of feeling, bladder and bowel problems, and how early complications appear are more strongly linked to where the spine and spinal cord are affected and how extensive the opening is. In other words, genetics may help explain why myeloschisis occurs, but it is much less useful for forecasting the exact symptom pattern or severity.
Causes and risk factors
Myeloschisis develops very early in pregnancy when the tissue that forms the spine and spinal cord does not close as it should. Genetic susceptibility can play a role, and inherited or new gene changes that affect early spinal development or folate use may raise the chance. Risk factors for myeloschisis also include too little folic acid before and during early pregnancy, diabetes, obesity, and some anti-seizure medicines. High body temperature in early pregnancy, such as from fever or hot tubs, may add to the risk. It is rarely just one factor, and the mix matters.
What are the most common causes or risk factors?
Myeloschisis usually does not have one single cause; it is thought to happen very early in pregnancy from a mix of inherited risk and outside factors when the baby’s spine and spinal cord do not close as they should. The strongest known risk factors are not getting enough folic acid before pregnancy and in the first weeks of pregnancy, having a personal or family history of a spine birth defect, and certain medicines used for seizures, especially valproate. Diabetes before pregnancy, obesity, and high body temperature in early pregnancy, such as from a fever or frequent hot tub use, can also raise the risk.
Environmental and biological risk factors
Myeloschisis develops very early in pregnancy, often before pregnancy is recognized. Risk factors for myeloschisis mainly involve conditions in the pregnant parent’s body and certain early exposures. Doctors often group risks into internal (biological) and external (environmental).
Low folate levels around conception raise the chance that the spinal tissues will not form and close normally. This is one of the best-established biological risk factors for myeloschisis.
Low vitamin B12 levels may also increase the risk, especially when folate levels are low at the same time. This vitamin helps cells grow and divide normally during the earliest weeks of pregnancy.
Diabetes present before pregnancy, especially if blood sugar is high early on, can increase the risk of myeloschisis and related neural tube defects. The most important window is the first few weeks, when the spine is forming.
A high body temperature in very early pregnancy, especially from fever, can raise risk. Intense outside heat exposure, such as frequent hot-tub or sauna use during that same early window, may also add to the chance of myeloschisis.
Genetic risk factors
For myeloschisis, genetic risk is usually complex rather than tied to one single gene. It’s usually a combination of influences rather than one clear cause. Many living with myeloschisis have no known family history, but having relatives with myeloschisis or another neural tube defect can raise the chance in a future pregnancy. In a smaller number of cases, myeloschisis appears alongside a chromosome condition or a broader genetic syndrome.
Family history: Having a close relative with myeloschisis or another neural tube defect raises the chance in a future pregnancy. This suggests inherited factors can matter even when no single gene change is found.
Complex inheritance: Myeloschisis usually does not follow a simple one-gene inheritance pattern. Instead, several inherited gene differences may work together to affect how the early spine and spinal cord form.
Folate genes: Some inherited gene changes affect how the body uses folate, which is important for early spinal development. These are among the better known genetic risk factors for myeloschisis, but they do not explain most cases on their own.
Chromosome changes: In a small number of pregnancies, myeloschisis happens along with a chromosome change. This is more likely to be considered when there are other birth differences as well.
Genetic syndromes: Rarely, myeloschisis can be part of a broader genetic syndrome that affects development in several parts of the body. When this is suspected, genetic testing may help clarify whether there is an underlying inherited condition.
Recurrence risk: After one pregnancy affected by myeloschisis or a related neural tube defect, the chance is higher in a later pregnancy than it is for the general population. Even so, a higher genetic risk does not mean it will happen again.
Lifestyle risk factors
Myeloschisis is present from birth, so lifestyle habits do not cause it. However, how lifestyle affects myeloschisis can be very important for skin protection, mobility, bowel and bladder care, bone health, and infection prevention. The most relevant factors are the daily habits that influence complications and day-to-day function.
Long periods in one position can raise the risk of pressure sores because sensation and movement are often limited in myeloschisis. Regular repositioning, careful skin checks, and good seating support can help protect vulnerable areas.
Safe, adapted movement can help maintain strength, joint range, circulation, and respiratory fitness in people living with myeloschisis. Too little activity can worsen deconditioning, contractures, and loss of function.
Excess weight can make transfers, wheelchair mobility, bracing, and daily care harder for someone with myeloschisis. It can also increase pressure on the skin and raise the risk of sores and reduced independence.
Good protein, calorie balance, calcium, vitamin D, and fiber intake can support wound healing, bone health, and bowel regularity in myeloschisis. Poor nutrition may contribute to constipation, weaker bones, and slower recovery from skin injury.
Risk prevention
Because myeloschisis develops very early in pregnancy, prevention mostly means lowering the chance of it happening before conception and in the first weeks afterward. The most important step is getting enough folic acid before pregnancy starts, since many people do not know they are pregnant during the period when the spinal cord is forming. Prevention is about lowering risk, not eliminating it completely. If there is a personal or family history of a neural tube defect, a clinician may advise a higher-dose folic acid plan before pregnancy.
Taking folic acid every day before pregnancy and during early pregnancy is the best-known way to lower the risk of myeloschisis. For most people, this means starting at least 1 month before conception and continuing through the first trimester.
People with a past pregnancy affected by myeloschisis or another neural tube defect often need a higher folic acid dose than usual. This should be planned with a doctor before trying to conceive, because the dose is different from standard prenatal vitamins.
Some medicines can raise the risk of neural tube defects if taken around conception or in early pregnancy. Review prescription drugs, over-the-counter medicines, and supplements with a clinician before pregnancy so safer options can be considered when possible.
Poorly controlled diabetes before and in early pregnancy can increase the risk of myeloschisis. Steady blood sugar control before conception is especially important, since the earliest changes happen before any early symptoms of pregnancy are obvious.
Can you prevent Myeloschisis?
Myeloschisis cannot always be prevented, and it can happen even when someone does everything right. The clearest way to lower the risk of this type of serious spine birth defect is to get enough folate, a B vitamin, before becoming pregnant and during the first weeks of pregnancy; keeping diabetes well controlled and reviewing seizure medicines with a doctor before pregnancy may also help reduce risk, but they cannot fully prevent it.
Transmission
Myeloschisis is not infectious, so it cannot be caught from someone else through touch, the air, food, or close contact. It develops very early in pregnancy, when the tissue that should close over the spinal cord does not close properly.
When people ask about how Myeloschisis is inherited, the answer is that there usually is not a single gene passed directly from parent to child; instead, the risk seems to come from a mix of genetic susceptibility and pregnancy-related factors. Most cases of Myeloschisis happen in families with no prior history, but having one pregnancy affected by a neural tube defect can raise the chance in a future pregnancy.
When to test your genes
Genetic testing is not usually used to detect myeloschisis early, because it is most often found on prenatal ultrasound and maternal blood screening. Testing may be helpful if a pregnancy is affected, if there is a family history of neural tube defects, or if other birth differences suggest a chromosomal or syndromic cause.
Diagnosis
Myeloschisis is usually recognized because the spinal cord and nearby tissues do not close normally during early development, so doctors often spot it before birth or immediately after delivery. The diagnosis of Myeloschisis is based on visible findings and imaging rather than symptoms a baby can describe. Doctors usually begin with prenatal ultrasound when possible, then confirm the extent of the spinal opening with other scans or a newborn exam.
A pregnancy ultrasound can often show an open spinal defect along the back and changes in the baby's spine or head. These findings may raise concern for Myeloschisis before birth and help plan delivery and specialist care.
During pregnancy, a blood test may show a higher-than-expected level of alpha-fetoprotein, also called AFP. This does not confirm Myeloschisis on its own, but it can support the need for closer imaging.
A fetal MRI may be used to look more closely at the spinal defect when ultrasound findings are unclear or more detail is needed. It can help show how much of the spinal cord is exposed and whether nearby structures are also affected.
After birth, doctors examine the back for an open area where the spinal cord tissue is exposed without skin covering it. This physical appearance is often very clear and is a key part of the genetic diagnosis of Myeloschisis and related neural tube defects.
How is Myeloschisis diagnosed?
Myeloschisis is usually diagnosed before birth with a pregnancy ultrasound, which can show that the baby’s back and spinal cord have not closed normally, and a maternal blood test may also raise concern. If the finding is not clear, doctors may use a fetal MRI, which is a detailed scan, to get a better look. After birth, it is often diagnosed by examining the open area on the back and confirming it with imaging, while genetic testing is not usually needed to make the diagnosis but may sometimes be offered to look for related conditions or future pregnancy risk.
Stages of Myeloschisis
Myeloschisis does not have defined progression stages. This is because myeloschisis is a birth defect that is present from early development in pregnancy, rather than a condition that moves through mild, moderate, and severe phases over time. Doctors usually start with a conversation about pregnancy and birth history, and myeloschisis is usually identified on prenatal ultrasound or at birth during a physical exam. After diagnosis, care focuses on checking the spine and nerves, looking for related problems such as weakness or bladder and bowel issues, and understanding how severe the findings are rather than tracking early symptoms of myeloschisis through stages.
Outlook and prognosis
The outlook for myeloschisis is generally poor because the spinal cord and surrounding tissues are left open and severely damaged before birth, often causing profound, permanent paralysis, loss of sensation, and bowel and bladder dysfunction below the level of the defect. Prognosis depends on how high on the spine the lesion occurs and whether there are associated problems such as hydrocephalus, Chiari II malformation, infections, or other congenital anomalies. Newborns who survive usually need urgent neurosurgical and supportive care, but even with treatment, major lifelong physical disability is common and many children require ongoing rehabilitation, orthopedic care, and mobility assistance. Mortality is highest in the neonatal period and infancy, especially when myeloschisis is accompanied by severe brain abnormalities, respiratory complications, or overwhelming infection. Among survivors, life expectancy can vary widely and is strongly influenced by the severity of neurologic injury and the quality of long-term multidisciplinary care.
Long-term effects
Many living with myeloschisis have lifelong effects on movement, sensation, and bladder or bowel control, and these can shape daily routines from infancy onward. Long-term effects vary widely, but the condition often involves several body systems rather than only the spine. As children grow into adulthood, needs may change, especially around mobility, learning, skin care, and kidney health.
Myeloschisis often causes lasting weakness or paralysis below the level of the spinal opening. For many, this can mean difficulty with standing, walking, balance, or changing position as they grow.
Reduced feeling below the affected area can make it hard to notice pain, pressure, heat, or skin injury. This can lead to unrecognized cuts, burns, or pressure sores over time.
Many people with myeloschisis have a bladder that does not store or empty urine normally. Over the years, this can raise the risk of urine leakage, repeated urinary infections, and kidney damage if bladder function remains poor.
Long-term bowel effects can include constipation, stool leakage, or trouble fully emptying the bowels. These problems may affect comfort, independence, school life, work, and social confidence.
How is it to live with Myeloschisis?
Living with myeloschisis usually means living with a very severe spinal cord birth difference that affects movement, sensation, and control of the bladder and bowels from the first days of life. Many people with myeloschisis need complex medical care, mobility support such as a wheelchair, help with skin care and daily routines, and regular visits with specialists, so day-to-day life often involves careful planning rather than spontaneity. For parents, siblings, and other caregivers, the condition can bring major emotional, physical, and financial demands, but with coordinated care, rehabilitation, and practical support, many families build steady routines and find ways to focus on comfort, participation, and quality of life.
Treatment and drugs
Myeloschisis is a severe birth defect in which the spinal cord is exposed at birth, so treatment starts right away with careful protection of the area and surgery, usually within the first day or two, to lower the risk of infection and further nerve injury. Surgery cannot reverse nerve damage that has already happened, but it can help prevent added harm and is a key part of treatment for myeloschisis. Treatment plans often combine several approaches. Many people with myeloschisis also need ongoing care for related problems such as fluid buildup in the brain, weakness or paralysis in the legs, bladder and bowel control problems, skin care, and help with movement, often with physical therapy, braces, wheelchairs, or other equipment. Because the effects can vary widely, treatment for myeloschisis is usually coordinated by a team that may include neurosurgery, rehabilitation, urology, orthopedics, and primary care, with regular follow-up as a child grows.
Can you cure Myeloschisis?
No, myeloschisis cannot be cured. Treatment focuses on closing and protecting the open area of the spine, usually with surgery soon after birth, and on managing problems it can cause, such as weakness, trouble moving, bladder or bowel problems, and fluid buildup around the brain. While care can improve comfort, safety, and day-to-day function, it cannot undo damage to the spinal cord that has already happened.
Non-drug treatment
Day-to-day care for people with myeloschisis usually involves several therapies working together rather than one single treatment. Because the spinal cord is exposed at birth, treatment often starts quickly to protect the tissue, lower the risk of infection, and support breathing, feeding, movement, and comfort. Supportive therapies can also help with longer-term needs such as walking, sitting, bladder and bowel care, and skin protection. The best plan depends on how much of the spine is affected and whether problems like hydrocephalus, weakness, or the early symptoms of myeloschisis are present.
Early surgery is usually used to cover and protect the open spinal area. This helps lower the risk of infection and further injury, although it cannot reverse nerve damage that has already happened.
Many living with myeloschisis also need close monitoring for extra fluid around the brain. If this develops, surgery such as a shunt or another drainage procedure may be needed to protect brain function.
Physical therapy helps build strength, improve positioning, and support safe movement as a child grows. For many, this can mean working on head control, sitting balance, transfers, and ways to move around more comfortably.
Occupational therapy focuses on daily skills such as feeding, dressing, play, and later school activities. It can also help with hand use, seating, and adaptive equipment that makes everyday tasks easier.
Your genes may have an impact on how drugs work for you
For myeloschisis, gene differences usually do not play a big role in choosing medicines, because treatment is mostly based on urgent supportive care and often surgery rather than long-term drug treatment. In other words, there are no well-established gene-based medication rules that doctors routinely use for people living with myeloschisis. Even so, if a child needs medicines for pain, infection, or other related problems, the care team still watches closely for side effects and adjusts treatment to fit that child’s overall health.
Pharmacological treatments
Treatment for myeloschisis usually centers on urgent surgery and long-term supportive care, rather than a medicine that repairs the spinal opening itself. Drug treatment for myeloschisis is mainly used to manage pain, lower infection risk, and help with bladder or bowel problems that can come with nerve injury. Not everyone responds to the same medication in the same way. The exact medicines depend on the child’s symptoms, age, and any related complications such as hydrocephalus or repeated urinary infections.
Antibiotics such as ampicillin and gentamicin may be used around birth or surgery if doctors are concerned about infection. Because the spinal tissues are exposed, preventing or treating infection can be urgent.
Acetaminophen and ibuprofen are often used for mild to moderate pain after procedures or during recovery. If pain is more severe, short-term opioid medicines such as morphine may be needed with close monitoring.
Oxybutynin is commonly used when nerve-related bladder problems cause leaking, high bladder pressure, or poor emptying. Some children may use similar medicines such as tolterodine if bladder symptoms continue.
Polyethylene glycol, senna, or docusate may be used to treat constipation, which is common when the nerves that help control the bowel are affected. For many families, this can mean fewer painful stools and a more predictable routine.
Genetic influences
For families facing myeloschisis, one of the first questions is often whether it could happen again. It’s natural to ask whether family history plays a role. In most cases, myeloschisis does not come from a single inherited gene; instead, risk seems to reflect several genes working together with factors such as folate levels and health during early pregnancy. Some gene changes may affect how the body uses folate or how the spinal cord and backbone form in the first weeks after conception, which can raise the chance of neural tube defects, including myeloschisis. If you have had one pregnancy affected by myeloschisis or a close relative with a neural tube defect, the risk of myeloschisis in a future pregnancy is higher than average, although most future pregnancies are still not affected. Because there usually is not one clear gene to test for, genetic counseling is often more useful than broad genetic testing for understanding family risk and planning next steps.
Is Myeloschisis genetic?
Genetics can raise the risk of myeloschisis, but it is usually not caused by a single inherited gene change. Many living with myeloschisis are affected by a mix of genetic susceptibility and environmental factors, especially low folate early in pregnancy.
Having a genetic risk is not necessarily a diagnosis
Genetic variants, or changes in genes, are a normal part of being human and are common throughout the population. Most of these variants do not directly affect health and simply reflect natural differences among people. For many genes, carrying a variant connected to a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For babies with myeloschisis, treatment is usually centered on urgent surgery and careful supportive care, because the exposed spinal tissue needs protection as early as possible. Not every difference in response is genetic, but genes involved in early spinal cord development and folate handling may help explain why myeloschisis happens in some families or occurs with other birth differences. Even so, genetic testing does not usually decide the main treatment options for myeloschisis, and there is no drug chosen specifically for a known gene change in most cases. Medicines used around treatment, such as antibiotics, pain relief, or drugs for bladder and bowel problems, are generally selected based on the baby’s needs, age, weight, kidney function, and any other medical issues rather than pharmacogenetic results. If doctors suspect an underlying genetic syndrome or chromosome condition, that information can still help guide the broader care plan, expected complications, and counseling for future pregnancies.
Interactions with other conditions
For families affected by myeloschisis, health concerns often extend beyond the spine itself, because this condition can occur alongside other serious problems that need close medical care. Babies with myeloschisis may also have fluid buildup around the brain, called hydrocephalus, and some have changes in the lower part of the brain that can affect breathing, feeding, or swallowing. Because the spinal tissues are exposed, there is also a high risk of infection, including meningitis, which can become life-threatening without urgent treatment. Another important aspect is how it may link with other diseases: many children with myeloschisis also have bladder or bowel dysfunction, which can raise the chance of repeated urinary tract infections and kidney damage over time. Some may find that weakness or loss of feeling in the legs leads to joint problems, skin sores, or trouble with movement as they grow. These related issues are part of why early treatment and long-term follow-up matter so much in myeloschisis.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Myeloschisis?
Other forms of spina bifida, especially myelomeningocele and meningocele, can cause similar problems, such as weakness in the legs, changes in feeling, and bladder or bowel trouble. Doctors may also need to tell myeloschisis apart from other rare but serious open spine birth defects, because these conditions can look similar at birth even though the amount of nerve damage may differ.
History
For families, myeloschisis has often been one of the most serious birth conditions affecting the spine and nervous system, with major effects present from the very start of life. Long before modern scans or newborn intensive care, doctors recognized that some babies were born with an open area along the back and severe weakness or loss of movement below it. Early medical descriptions grouped these findings with other forms of spina bifida, because the outward changes could be seen even when the underlying anatomy was not fully understood.
Medical classifications changed as doctors learned to tell apart different open spinal conditions. Over time, myeloschisis came to be recognized as a particularly severe form in which the developing spinal cord remains open and exposed rather than forming in the usual way. Not every early description was complete, yet together they helped shape the clearer terms used today and improved how specialists explain the condition to families.
By the late 19th and 20th centuries, advances in anatomy, pathology, and later imaging gave doctors a much better picture of what was happening during early fetal development. This also helped explain why myeloschisis is often linked with other problems involving the brain, spinal fluid, bladder, bowel, and leg movement. As newborn care improved, treatment shifted from simply describing the condition to trying to protect exposed tissue, manage complications, and support longer-term care.
In recent decades, awareness has grown around neural tube defects as a group, including myeloschisis. Researchers later identified that these conditions arise very early in pregnancy, often before someone knows they are pregnant, and public health efforts such as folic acid supplementation helped lower the number of some neural tube defects in many countries. Even so, myeloschisis remains a rare and very serious condition, and much of today’s care focuses on early diagnosis, careful pregnancy counseling, delivery planning, and support for the complex needs a child may have after birth.
Knowing this history can make today’s approach easier to understand. What once could only be described by what doctors saw at birth can now often be detected before delivery, and families can be prepared for the medical team, surgery decisions, and the likely symptoms of myeloschisis from the first days of life.